CRISPR Screens Uncover Protective Effect of PSTK as a Regulator of Chemotherapy-Induced Ferroptosis in Hepatocellular Carcinoma

CRISPR-based loss-of-function genetic screens were used to target 18,053 protein-coding genes in hepatocellular carcinoma cells to identify chemotherapy-related synthetic lethal genes in these cells.